Market Trends of Amniotic Membrane Industry
The Surgical Wounds Segment is Expected to Grow Significantly During the Forecast Period
- Amniotic membrane has several antimicrobial and biological properties in corneal surgery, as it enhances epithelialization, reinforces adhesion of basal epithelial cells, maintains epithelial phenotype, and modulates the proliferation of normal corneal, conjunctival, and limbal fibroblast. These membranes also prevent apoptosis and inhibit scarring, inflammation, and neovascularization. Several research studies have underlined the diverse applications of amniotic membranes for the surgical treatment of various wounds. For instance, a study published in Membrane in June 2022 highlighted the vast potential of the human amniotic membrane in tissue engineering and tissue regeneration and has shown desirable results in vascular, bone repair, cartilage repair, and oral surgery.
- Also, the market players' key developments are expected to boost the growth of the segment. For instance, in October 2022, the hydrated human amnion membrane allograft by BioLab Sciences, Membrane Wrap - Hydro, was recognized by the United States Food and Drug Administration (US FDA) Tissue Reference Group (TRG) as a human cell, tissue/cellular/tissue-based product (HCT/P). The product is indicated for the management of surgical wounds and other wounds. Such recognition by the USFDA would enable the product to be easily reimbursed by the insurance bodies, which would make the product very affordable and in high demand.
- In September 2022, MiMedx Group Inc. launched its Amnioeffect, a tri-layer PURION-processed human tissue allograft consisting of the placenta's chorion, amnion, and intermediate membrane layers. The products offer suitable healing of the surgical wound. The company stated that the product launch would expand its surgical recovery product portfolio. Such developments would create more opportunities for the amniotic membrane to be used to manage surgical wounds, which would meet the high demand for surgical wound healing.
- Therefore, owing to the above factors, the surgical wounds segment is growing and is expected to grow significantly during the forecast period.
Understand The Key Trends Shaping This Market
Download PDF
North America is Expected to Grow Significantly During the Forecast Period
- North America is the largest regional market in revenue, owing to high healthcare expenditure, highly developed healthcare infrastructure, and the recent developments by the market players. For instance, according to the data published by the United States Centers for Medicare & Medicaid Services in February 2023, the national healthcare expenditure increased by 2.7% to USD 4.3 trillion in 2021 compared to 2020.
- Also, the key developments by market players are anticipated to boost market growth in North America. For instance, in November 2022, Verséa announced rolling out the Biovance 3L ocular tri-layer human amniotic membrane.
- The rigorous research and development in countries across North America is expected to boost the amniotic membrane market growth in the region. For instance, in March 2023, at the annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS) in Boston, ophthalmologists presented research shedding light on the application of cryopreserved amniotic membrane (CAM). A notable advancement included using BioTissue’s Prokera Slim to enhance the ocular surface in various clinical scenarios.
- Therefore, the market growth is expected in North America due to these factors.
Get Analysis on Important Geographic Markets
Download PDF
